Clinical Trial Update: Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing pregabalin to venlafaxine XR and placebo for generalized anxiety disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Generalized Anxiety Disorder

Drugs mentioned

• Pregabalin (Pregabalin)
• Venlafaxine XR (venlafaxine)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Anxiety | Phase 3 | Status: COMPLETED